A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan
Keyword(s):
Rhabdomyolysis is caused by extensive damage to skeletal muscles resulting in elevated creatine phosphokinase (CPK), Lactate dehydrogenase (LDH), and aspartate aminotransferase (AST), leading to life-threatening consequences like acute renal failure, cardiac arrhythmias, and hyperthermia. A variety of causes for muscle damage are known, and one of the most common is drug-induced. Statins and many other agents are known to induce muscle damage, but here we report Entresto™ (Sacubitril/Valsartan) induced rhabdomyolysis which has not been previously reported as solely responsible in the literature.
2004 ◽
Vol 19
(7)
◽
pp. 1916-1917
◽
Keyword(s):
2017 ◽
Vol 27
(12)
◽
pp. 1108-1113
◽
2020 ◽
Vol 2
(2)
◽
pp. 67
2019 ◽
Vol 69
(8)
◽
pp. 1440-1442
◽
2002 ◽
Vol 324
(6)
◽
pp. 342-344
◽